Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsy
Open Access
- 20 August 2015
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 6 (31) , 32169-32176
Abstract
Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsyKeywords
This publication has 35 references indexed in Scilit:
- Prognostic model for survival based on readily available pretreatment factors in patients with advanced pancreatic cancer receiving palliative chemotherapyInternational Journal of Clinical Oncology, 2015
- Nonsteroidal Anti-Inflammatory Drugs and Prostatic DiseasesBioMed Research International, 2014
- Association between systemic inflammatory markers and serum prostate-specific antigen in men without prostatic disease-The 2001-2008 National Health and Nutrition examination surveyThe Prostate, 2014
- Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancerJournal of Surgical Oncology, 2011
- Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancerBritish Journal of Cancer, 2011
- From endoplasmic-reticulum stress to the inflammatory responseNature, 2008
- A Prospective Study of Serum C-Reactive Protein and Colorectal Cancer Risk in MenCancer Research, 2006
- Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per MilliliterNew England Journal of Medicine, 2004
- Systemic inflammatory response predicts survival following curative resection of colorectal cancerBritish Journal of Surgery, 2003
- PROSTATE SPECIFIC ANTIGEN: A DECADE OF DISCOVERY-WHAT WE HAVE LEARNED AND WHERE WE ARE GOINGJournal of Urology, 1999